REGULUS THERAPEUTICS INC - COM NEW (RGLS)

CUSIP: 75915K200

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM NEW
Total 13F shares
18,410,400
Share change
+10,593,318
Total reported value
$24,803,224
Put/Call ratio
32%
Price per share
$1.35
Number of holders
28
Value change
+$14,493,226
Number of buys
17
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 75915K200?
CUSIP 75915K200 identifies RGLS - REGULUS THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REGULUS THERAPEUTICS INC - COM NEW (RGLS) as of Q4 2020

As of 31 Dec 2020, REGULUS THERAPEUTICS INC - COM NEW (RGLS) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,410,400 shares. The largest 10 holders included NEA Management Company, LLC, BVF INC/IL, Point72 Asset Management, L.P., Sarissa Capital Management LP, CVI Holdings, LLC, VICTORY CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Tower Research Capital LLC (TRC), and GEODE CAPITAL MANAGEMENT, LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.